Renalytix PLC
OTC:RTNXF
Renalytix PLC
OTC:RTNXF
Price:
0.091
USD
Market Closed
Market Cap:
$15.1m
Balance Sheet
Balance Sheet Decomposition
Renalytix PLC
Renalytix PLC
Balance Sheet Decomposition is not available for
Renalytix PLC
Renalytix PLC
Balance Sheet
Renalytix PLC
Renalytix PLC
Currency: USD
| Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
0
|
9
|
13
|
65
|
41
|
25
|
5
|
|
| Cash |
0
|
0
|
13
|
65
|
41
|
25
|
5
|
|
| Cash Equivalents |
0
|
9
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
1
|
9
|
3
|
1
|
1
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Other Current Assets |
0
|
0
|
4
|
1
|
1
|
1
|
0
|
|
| Total Current Assets |
0
|
9
|
19
|
76
|
47
|
28
|
7
|
|
| PP&E Net |
0
|
0
|
1
|
1
|
2
|
1
|
0
|
|
| PP&E Gross |
0
|
0
|
1
|
1
|
2
|
1
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Intangible Assets |
0
|
18
|
17
|
18
|
14
|
13
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
2
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
1
|
2
|
7
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
29
+50 999%
|
41
+43%
|
103
+148%
|
63
-38%
|
42
-33%
|
7
-83%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
0
|
2
|
2
|
2
|
3
|
3
|
|
| Accrued Liabilities |
0
|
0
|
1
|
5
|
5
|
9
|
5
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
5
|
5
|
4
|
|
| Other Current Liabilities |
0
|
0
|
2
|
1
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
1
|
5
|
7
|
12
|
16
|
12
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
8
|
8
|
4
|
|
| Total Liabilities |
0
N/A
|
1
+1 044%
|
5
+607%
|
7
+40%
|
20
+169%
|
24
+18%
|
16
-32%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
6
|
35
|
4
|
53
|
99
|
145
|
|
| Additional Paid In Capital |
0
|
34
|
0
|
76
|
85
|
105
|
122
|
|
| Other Equity |
0
|
0
|
1
|
15
|
10
|
12
|
13
|
|
| Total Equity |
0
N/A
|
28
N/A
|
36
+28%
|
95
+164%
|
43
-55%
|
18
-57%
|
9
N/A
|
|
| Total Liabilities & Equity |
0
N/A
|
29
+50 999%
|
41
+43%
|
103
+148%
|
63
-38%
|
42
-33%
|
7
-83%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
54
|
54
|
59
|
71
|
73
|
94
|
154
|
|
Switch to:
Switch to:
See Also
Discover More
